tradingkey.logo
tradingkey.logo
Search

Lilly rises after launch of weight-loss drug Mounjaro in India

ReutersMar 20, 2025 2:44 PM
facebooktwitterlinkedin

Shares of drugmaker Eli Lilly LLY.N rise 1.77% to $852.32

Eli Lilly launches its blockbuster diabetes and weight-loss drug Mounjaro in India beating rival Novo Nordisk NOVOb.CO

The once-weekly injection approved by India's drug regulator, is priced at 4,375 rupees ($50.67) for a 5 mg vial and 3,500 rupees ($40.54) for a 2.5 mg vial, its lowest dose

Novo's India team has been pushing the global leadership to launch its weight-loss drug, Wegovy, as early as 2025 in the country as opposed to the company's target of a 2026 launch

LLY stock up 10% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI